John Sperzel News Today

Filed Pursuant to Rule 433 Issuer Free Writing Prospectus dated May 6, 2024 Relating to Preliminary Prospectus dated May 6, 2024 Registration No....

28.03.2024 - LEXINGTON, Mass., March 28, 2024 (GLOBE NEWSWIRE) - T2 Biosystems, Inc. (NASDAQ:TTOO), a leader in the rapid detection of sepsis-causing pathogens and antibiotic resistance genes, today announced that its multi-year capital equipment supplier ... Seite 1

T2 Biosystems, Inc. (NASDAQ:TTOO) Q4 2023 Earnings Call Transcript February 15, 2024 T2 Biosystems, Inc. isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Good day, everyone. And welcome to the T2 Biosystems Preliminary Fourth Quarter and Full Year 2023 Results […]

15.02.2024 - LEXINGTON, Mass., Feb. 15, 2024 (GLOBE NEWSWIRE) - T2 Biosystems, Inc. (NASDAQ:TTOO), a leader in the rapid detection of sepsis-causing pathogens and antibiotic resistant genes, today announced the execution of territory exclusive distribution ...

LEXINGTON, Mass., Feb. 07, 2024 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ:TTOO) a leader in the rapid detection of sepsis-causing pathogens and antibiotic resistance genes, announced today that the U.S.

T2 Biosystems, Inc. (NASDAQ: TTOO) shares are trading higher on Wednesday after the company submitted a 510(k) premarket notification to the U.S.

T2 Biosystems, Inc. (NASDAQ: TTOO) shares are trading higher Tuesday, though the stock remains down by more than 75% over the last month. What To Know:

Trip Taylor, IR Thank you, operator. I would like to remind everyone that comments made by management today and answers to questions will include forward-looking...

T2 Biosystems, Inc. (NASDAQ:TTOO) Q3 2023 Earnings Call Transcript October 12, 2023 Operator: Greetings. Welcome to T2 Biosystems Preliminary Third Quarter 2023 Financial Results and Business Update Call. At this time, all participants are in a listen-only mode. A question-and-answer session will follow the formal presentation. [Operator Instructions] Please note this conference is being recorded. […]

TTOO stock is continuing its plunge after T2 Biosystems reported preliminary third-quarter earnings, missing on revenue.